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Introduction
The GL-101 Glucose Analyser is manufactured in Japan by
Mitsubishi Chemical Industries Ltd, and marketed in theUK by
Anachem Ltd. A prototype machine was lent to the John
Radcliffe Hospital, Oxford, during late 1982 and a modified
model was installed in Good Hope Hospital, Sutton Coldfield,
in early January 1983.
The analyser is designed solely for the estimation of glucose
with sampling, calibration and production of result being
completely automatic. It has the ability to analyse both plasma
and urine samples and the sampling cycle can be interrupted at
any time to accommodate emergency samples. The instrument is
approximately 50cm high, 50cm wide and 50cm long and the
only service required is a single electric output socket, although
it is more convenient to site the analyser near a drain to take the
waste solutions from the instrument. The sampler has a 40-
position tray which accepts standard analyser cups and has an
optional sample-identification system utilizing coded cards
which fit over the cups. Sampling, dilution with water and the
addition ofphosphate buffer is achieved by means of automatic
syringes. The diluted sample is pumped through a pretreatment
column of basic anion-exchange resin, to remove possible
interfering substances, before the addition ofbuffer and passage
through a column of glucose oxidase (GOD) immobilized on
glass beads. The manufacturer claims that 2000 samples can be
passed through the pretreatment column and 500 samples
through the GOD column before replacement is necessary. The
amount of hydrogen peroxide formed is proportional to the
glucose present and is measured by an electrode system
positioned immediately above the enzyme column.
By identification of the cup containing the standard and the
value of the standard, the analyser will calibrate itself and
calculate and print-out the values of test samples. However, it is
possible to override the manufacturer’s standard value and enter
any other positive integer.
The instrument samples at up to 120 samples/h utilizing 6/A
ofplasma (although requiring 20 #1 in the sample cup) or 2/B of
urine. Results are printed on paper on a 24-column printer, in
addition to being displayed by the LED screen; an RS 232C
unidirectional interface card is available as an optional extra to
allow direct transmission of results to a main laboratory
computer.
Safety
The only moving parts accessible to the operator are the sampler
probe and turntable. The small distance of travel ofthe sampler
probe, facilitated by the compact design of the machine, is
unlikely to present a hazard to the operator. The only reagents
required are phosphate buffer and water and spillage of these
onto the electronic components is unlikely.
Microbiological safety
The sampler area is easily cleaned but it is difficult to disinfect
the tubing. Dissemination of infective material was assessed as
recommended by Broughton et al. [- 1]. Plates containing culture
medium were placed on and around the machine, a tray of 40
aliquots of a concentrated suspension of Bacillus 91obigii was
sampled and analysed as serum and the plates then incubated for
three days.No growth ofthe Bacillus was found on any plate and
air sampled from the vicinity of the sample probe showed no
contamination. At the end of the run a sample of water was
taken for culture from the rinse cuvette and the columns were
removed, perfused with broth and incubated. No Bacillus
globigii colonies were grown from the rinse water but, not
surprisingly, the organism was cultured from both columns.
It is concluded that no significant aerosol formation or
splashing occurs. The conditioning cycle at the end of each run
does not remove trapped organisms from the columns.
However, as the columns have a limited life, this should not be a
problem; discarded columns should be treated as contaminated
material.
Analytical evaluation
Precision
Serum pools containing low, medium and high concentrations
of glucose were prepared from Gibco mycoplasma-screened
horse serum. Glucose was added to give a final concentration of
approximately 19 mmol/l for the high pool and approximately
10mmol/l for the medium pool. No glucose addition was
necessary for the low control as the horse serum contained
approximately 3mmol/1 of endogenous glucose. The serum
pools were divided into 8 ml aliquots and stored at -40C.
To assess precision of the Mitsubishi GL-101 the following
tray layout was used to include the effects of carry-over on
precision [2]:
Low pool: Cup Nos. 9, 11, 14, 15, 20, 21, 24, 27, 28, 34
37, 39.
Medium pool: Cup Nos. 6, 7, 12, 16, 18, 19, 22, 23, 26, 30,
31, 33.
High pool: CupNos. 5, 8, 10, 13, 17, 25, 29, 32, 35, 36,
38, 40.
The instrument was calibrated at the start of each tray and
control materials placed in cups to 4. Identical trays were run
on 40 occasions; once in the morning and once in the afternoon
of 20 working days. Fresh aliquots of serum were thawed each
day. For comparative purposes the tray was also analysed daily
on the Beckman glucose analyser, this machine being re-
calibrated every 10 samples to simulate normal operation.
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Histograms of all results obtained in the precision study on
the Mitsubishi GL-101 and Beckman glucose analyser are
shown in figures and 2 respectively. It is interesting that
although the GL-101 purports to measure glucose concen-
tration to two places of decimals it will only print certain
numbers, for example a result for the medium pool may be 9.79,
9.83 or 9"89 but none of the intermediate values. The intervals
correspond to approximately mg/dl and the effect may be due
to the electronic arithmetic package which was originally
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Figure 1. Histograms of results obtained during the
precision stud), on the Mitsubishi GL-101.
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Figure 2. Histograms of results obtained during the
precision study on the Beckman glucose analyser.
designed to produce results in mg/dl and subsequently con-
verted to mmol/1. Figures 3 and 4 show the variation of the
within-batch mean and within-batch standard deviation re-
spectively, for each serum pool, obtained on both instruments
throughout the period of study. The overall precision data is
shown in table 1.
The precision of the GL-101 is adequate for normal, routine
use and is superior to that of the Beckman glucose analyser
which was formerly in routine operation at Good Hope
Hospital. MitSubishi quote a CV of better than1 at a glucose
concentration of 10mmol/1; approximately half the authors’
value. It appears that Mitsubishi’s quoted CV is based on one
run of identical specimens; therefore the authors’ figure, which
includes the effect of carry-over and day-to-day variations, is a
better indication of the precision one would expect to obtain in
routine operation. Analysis of 40 consecutive aliquots of a
10mmol/1 standard gave a mean value of 10.02 mmol/1, SD of
0.09mmol/l and CV of 0.9, which meets the manufacturer’s
specification.
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Figure 3. Variation of within-batch meanfor each serum
pool during the precision study. Mitsubishi GL-
101, [-] [-] Beckman glucose analyser.
Comparison with other methods
To assess the accuracy of th,e Mitsubishi GL-101 a selection of
patients’ samples obtained, over a period of two weeks were
analysed on both the Mitsubishi GL-101 and the Beckman
glucose analyser. Results are shown in figure 5. The regression
line was calculated for pairs of results less than 20mmol/1 and
22S. Oldfield et al. Evaluation of the Mitsubishi GL-101
0.2
0.1
0.5
0.2
0.1
0.6
0.4
0.2
20 40
Run number
Figure 4. Variation ofwithin-batch standard deviationfor
each serum pool during the precision study.
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found to have an intercept Of 0.6 mmol/1 and a gradient of 0"98.
The higher results obtained using the Beckman machine for
samples with a glucose concentration in excess of 23 mmol/1
were subsequently shown to be a dilution error ofdouble-filling
the Beckman analytical cell with glucose oxidase reagent. A
similar correlation study compared results of glucose analyses
using the Mitsubishi GL-101 and the glucose oxidase (GOD
PAP) method of BCL Ltd using a Gilford 3500 spectrophoto-
meter; the latter method being in current use in the John
Radcliffe Hospital.
Results are shown in figure 6 and the regression line had a
gradient of0.97 and an intercept of 0" 18. The large positive bias
of the Mitsubishi instrument at low glucose concentrations
when compared to the Beckman machine is worrying. The effect
may be partly explained by the sensitivity of the electrode to
solutions containing protein (see below). The smaller intercept
obtained in the second correlation may well be due to the
different response of a different electrode to protein or other
potentially interfering substances. Unfortunately it was im-
possible to obtain a new electrode system to permit further tests
to be made before this publication.
Mitsubishi GL-101 Beckman
Low pool
Medium pool
High pool
Mean 3.26 2.74
SD 0.12 0.17
CV 3.6 6.1
Mean 9.74 9.53
SD 0.19 0.25
CV 1.9 2"6
Mean 18.43 18.50
SD 0"30 0’53
CV 1.7 2.8
Table 1. Precision data obtained on the Mitsubishi GL-
101 and Beckman glucose analyser. See text for details.
Linearity
To investigate linearity of response of the GL-101 when set up
to measure plasma glucose, a 50mmol/1 aqueous glucose
standard was diluted with water to give a series ofsolutions with
a range of glucose concentrations from 0 to 50mmol/l. The
instrument was calibrated with a 10mmol/1 standard and an
identity flag to indicate the standard’s concentration and each
dilution was measured in duplicate, the series being run in both
ascending and descending order. The GL-101 produced a linear
response over the entire range tested (figure 7). Mitsubishi claim
only that a linear response is obtained for samples with a glucose
concentration of 40mmol/1 or less and an asterisk is printed
alongside higher results to indicate their unreliability. It was
subsequently found that the GL-101 would not print a result if
the glucose concentration was greater than 60mmol/1.
A second linearity experiment was performed with the
instrument calibrated with a 30mmol/1 standard and the urine
standard flag. An aqueous solution of approximately
500 mmol/l glucose was prepared and a series ofdilutions made.
The series was again run in ascending and descending order.
Figure 8 shows that the response of the GL-101 under these
conditions (sampling 2 #1) is linear up to a concentration of
250mmol/l.
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Figure 5. Comparison ofpatients’ results obtained on the
Mitsubishi GL-101 with those obtained on the Beckman
glucose analyser.
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Carry-over
Carry-over was measured by the procedure of Broughton et al.
[3]. Three successive aliquots of the high serum pool (al, aa, a3)
were followed by three successive aliquots ofthe low serum pool
(bt, bz, b3).
Carry-over was calculated from the following formula:
Carry-over x 100. a3-b3
This procedure was carried out on five occasions on each offive
days.
The mean carry-over was 1.21 and varied between 0.72
and 1.47.
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Figure 6. Comparison ofpatients’ results obtained on the
Mitsubishi GL-101 with those obtained on the Gilford 3500
using the BCL, GODPAP method.
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Figure 8. Linearity of the Mitsubishi GL-101 standar-
dized to measure urine glucose.
Interfe?ing substances
Oxalate and fluoride, as anticoagulant and preservative respect-
ively, are usually added to blood samples for glucose estimation.
Sodium oxalate was added to aliquots of horse serum to give a
range of concentrations up to 100mmol/l, approximately eight
times the normal concentration used. Similarly, potassium
fluoride was added to horse serum to provide concentrations up
to 330mmol/1, about 15 times the concentration used to inhibit
glycolysis. These and untreated samples were analysed on the
GL-101. No interference was present at any concentration
tested. However, a combination of 250mmol/1 fluoride and
250mmol/l oxalate produced a slight positive interference
(mean increase of 4"4o in apparent glucose concentration) on
one Mitsubishi analyser, but had no effect on the other. Again,
this may be due to a different response of the electrodes in the
two machines but no replacement electrodes could be obtained
to investigate this further. At the time ofthe study Anachem had
few spare parts in theUK and, unfortunately, have subsequently
decided to withdraw the instrument from the British market.
Ascorbic acid interference has been described in certain
glucose methods [4], however, Mitsubishi claim that the
pretreatment column removes ascorbate and other interfering
substances from the assayed sample. Horse serum was sup-
plemented with ascorbic acid to give a concentration of
200mg/1, approximately 10 times the upper limit of normal
plasma concentration in man, and glucose measurements were
compared to those on untreated serum. No interference was
observed.
It was postulated that haemolysis might interfere with
glucose measurements by the GL-101 as this instrument
measures hydrogen peroxide and haemoglobin has peroxidase
activity. Haemolysis was simulated by the addition of
erythrocyte lysate to horse serum to give a final haemoglobin
concentration of approximately 20g/1. Plasma (diluted to
contain the same concentration of glucose as the lysate) was
added to a second serum aliquot as a control, and water was
added to a third. Each preparation was analysed five times: the
mean measured glucose was 7.69mmol/1 in the haemolysed
preparation, compared to 8.38mmol/1 in the control and8.19mmol/l in the sample to which water had been added.
Therefore haemolysis causes a decrease in the apparent glucose
concentration.
Interference by the analgesics salicylate and paracetamol
was assessed by adding these drugs to horse serum.
Paracetamol, in particular, has been found to interfere with
some glucose methods [5]. Sodium salicylate was found to have
no effect, but 500mg/1 of paracetamol caused an increase in
apparent serum glucose of approximately 0.8 mmol/1. A dose-
response curve using aqueous solutions ofparacetamol showed
a linear relationship up to at least g/1 (figure 9), however, the
interference is not significant until high concentrations, only
observed in very severe overdoses, are achieved.
To test the effect of urine preservatives, boric acid (2 g/l),
thiomersal (0.2 g/l), 6M hydrochloric acid (10ml/1) and benzoic
acid (0"2 g/l) were added to separate aliquots ofa urine known to
contain glucose. The measured glucose concentration in each
was compared to that of the untreated specimen; the effect in
each case was not significant.
To test the effect of carbohydrates other than glucose,
aliquots of a normal urine were supplemented with sucrose,
lactose, galactose or xylose to a concentration of 2 g/1. These
sugars did not interfere with glucose measurements
A possible explanation for the consistently higher results
obtained on the Mitsubishi instrument compared to the
Beckman glucose analyser (see before) could be interference
from protein. To test this hypothesis, 10mmol/1 and 50mmol/1
glucose standards were diluted 10 times into saline or solutions
of human serum albumin or Sigma standard protein solution
(50g/1 human albumin, 30g/l human globulin) in saline and
measured glucose concentrations were compared. Protein ap-
pears to interfere (results shown in table 2) with the GL-101
giving a result of almost 0.4 mmol/1 for a solution 80 g/1 human
serum proteins. This is rather worrying, especially at low glucose
concentrations. The Beckman glucose analyser did not detect
any difference in glucose concentration between the saline
solutions and their protein-containing counterparts. It is un-
likely that the effect is due only to the viscosity of the solution
because the machine did not detect ’glucose’ in a viscosity-
adjusted flame photometer standard solution.
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Figure 9. Response of the Mitsubishi GL-101 to para-
cetamol solutions.
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Table 2. Effect of protein on glucose results. Solutions
containing O, 1 or 5 retool glucose in saline or saline
containing protein were prepared and glucose concen-
trations measured on the Mitsubishi instrument. (HSA:
human serum albumin.)
Prepared Mean measured
[glucose] [glucose]
(mmol/1) Diluent (mmol/l) n 5
Saline 4.96
72 g/1 HSA in saline 5.25
Saline 0.96
72 g/l HSA in saline 1.22
Saline 0.00
80 g/1 HSA in saline 0"28
40 g/1 HSA in saline 0" 17
50 g/1 HSA+ 30 g/1 globulin 0’38
in saline
Costs
To compare the costs of plasma glucose estimations on both
machines only direct analytical costs were calculated since blood
collection, separation of plasma, reporting of results and
associated clerical work are common to both procedures. Costs
were based on Good Hope annual work-load of approximately
15 000 samples; a number ofassumptions, described below, were
necessary.
Table 3 shows a breakdown of the expenses involved in
running the Mitsubishi GL-101 and table 4 shows a similar
analysis for the Beckman glucose analyser.
The capital cost per annum was based on a machine life of 10
years. The Beckman instrument was maintained on a fully
inclusive service contract and the extra costs incurred for day-to-
day maintenance were estimated at 150 per annum; however,
the future maintenance costs of the Mitsubishi instrument were
impossible to calculate and so were assumed to amount to 10
of the capital cost, as recommended by Broughton et al. [1].
Glucose oxidase reagent and pipette tips for the Beckman
instrument were supplied by Beckman. Replacement columns
and paper for the Mitsubishi machine are marketed by
Anachem. Other reagent costs are for FisonsAR grade disodium
hydrogen phosphate, potassium dihydrogen phosphate and
benzoic acid and BDH 50mmol/1 glucose standard.
Autoanalyser cups are supplied by BCL. The cost of distilled
water was difficult to estimate, so the price quoted is based on
the cost ofBDH AnalaR water. Staff time was calculated from a
salary of 6000 a year.
Despite the high capital cost of the Mitsubishi GL-101, the
cost per test is lower on this machine (0"18) than on the
Beckman glucose analyser (0.23) due to lower running costs. As
a large proportion of the cost on the GL-101 is capital
expenditure, the cost per test and the cost relative to the cost on
the Beckman glucose analyser would be lower if the work-load
were higher.
Subjective evaluation
The GL-101 is simple to use and can be left unattended to
complete the analysis of40 samples on the sample turntable after
which time it will automatically return to a standby condition.
On completion ofa run, the instrument emits a series ofpiercing
bleeps for 30 s: these are very irritating and a single bleep would
be adequate. The analyser is ideally suited to a heavy work-load
ofroutine specimens, but several features detract from its use as
an on-call instrument. If switched off, the instrument requires
30 min to warm up when reconnected, and if the power is left on
25S. Oldfield et al. Evaluation of the Mitsubishi GL-101
Table 3. Breakdown ofcostsfor the Mitsubishi GL-1 O1 at
an annual work-load of 15 000 samples.
Unit cost.
Cost per
1000
samples
Capital and maintenance
Capital 8000 over 10 years 53.33
Maintenance 10 of capital per annum 53.33
106.66
Assay costs
NazHPO4 6"81 per kg 0.31
KH2PO4 9.70 per 500 g 0.20
50 mmol/1 glucose
standard 3.11 per 500 ml 0" 15
Benzoic acid 6"73 per 500 g 0.10
GOD column 76 per pack of 5 6"08
Pretreatment column 76 per pack of 10 12.66
Printer paper 17 per 5 rolls 0"68
Water 2.26 per 51 6’75
Analyser cups 45.10 per 10000 4.51
31.44
Staff time
Staff time 45 min per day
Salary 6000 per annum 43.92
43.92
Total 182.02
it still performs a series ofconditioning cycles for a period ofup
to 10min. However, this is not adequate and if the machine has
not been used for several hours, the results of the first tray are
unreliable. It was necessary to run a short ’priming’ tray of five
standards and subsequently recalibrate the machine before
analysing patients’ samples.
During the time of the evaluation, several other problems
were encountered. The first problem was the result of an air
bubble in the electrode chamber. Once the bubble was dislodged
and removed, the instrument performed well for several weeks.
Further difficulties were met on the Jolin Radcliffe instrument as
a result ofa blockage at the top ofthe pretreatment column. This
was demonstrated by the junctions each side of the non-return
valves becoming disconnected. As the block was in the column
itself, the cause was not immediately obvious. Towards the end
ofthe evaluation, problems were encountered with the tempera-
ture control in the pump chamber ofthe prototype instrument at
the John Radcliffe Hospital. The fault was probably in the
thermostat mechanism, since the temperature continued to
increase although the circulation/cooling fan was operating.
This malfunction was also associated with the production and
accumulation of bubbles in the electrode chamber. The Good
Hope instrument had no problems in this respect but developed
a fault in the sample pump system. A microswitch controlling
the travel of the syringe pump was maladjusted and failed to
control the plunger movement. This resulted in the cessation of
analysis, the activation ofan alarm and the error message ’pump
over-run’. The first time this occurred, Anachem were prompt in
attending to the problem; however, when the problem recurred,
they were unhelpful as they had no spare parts in the UK--a
member of Good Hope’s laboratory staff corrected the fault.
A most disconcerting problem was the production of one
incorrect result in a sequence of answers, though this problem
was much more pronounced on the prototype analyser. These
spuriously low results were obvious when they appeared in tests
ofreplication or correlation with an alternative technique. In the
routine laboratory, they certainly would not become obvious. It
was suggested that small air bubbles in the bottom cone of the
26
Table 4. Breakdown of costs for the Beckman glucose
analyser at an annual work-load of 15 000 samples.
Unit cost
Cost per
1000
samples
Capital and maintenance
Capital
Service contract
Day-to-day
maintenance
Assay costs
Glucose oxidase reagent
Pipette tips
Staff time
Staff time
3785 over 10 years
500 per annum
150 per annum
55.35/
(pack includes standards)
20 per 1000
1"5 hours per day
Salary 6000 per annum
25"23
33.33
10’00
68"56
55"35
20"00
75’35
87.84
87.84
Total 231.75
sample cups might have resulted in insufficient sampling. Ifcare
was taken to remove any obvious air bubbles, performance on
the Good Hope instrument was satisfactory, however, this
explanation did not appear to account for all the spurious results
from the prototype instrument.
The sample identification collars were of little help and the
only ones used during the trial period were the standardization
card and the end-of-run detector.
Conclusions
The main impression was of a compact, well machined, simple-
to-operate analyser, which generally performed well. The carry-
over figure was acceptable and the correlation with the existing
methods was reasonable, although the bias at low concent-
rations of glucose with one instrument gave cause for concern.
The effect of other carbohydrates, ascorbic acid, urinary pre-
servatives, fluoride, oxalate and paracetamol were within
acceptable limits but grossly haemolysed specimens should be
avoided. Despite the high capital cost ofthe instrument, the cost
per test compared favourably with that ofan alternative, widely-
used instrument.
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